Virtual-Ports Receives CE Certification for Revolutionary Surgical Products

Virtual-Ports Ltd is thrilled to announce the attainment of CE certification under the new MDR (Medical Device Regulation 2017/745) for its groundbreaking surgical products. Renowned for their single-hand, multi-application design, Virtual-Ports’ solutions are set to revolutionize abdominal surgery by significantly improving visibility and access within the surgical space.

At the core of Virtual-Ports’ innovation is its MicroAnchoring™ technology, a proprietary system engineered to empower surgeons with enhanced control and clinical precision during laparoscopic procedures. This advancement not only reduces access ports and reliance on operating room assistance but also eliminates the need for a fourth robotic arm in Robotic-assisted surgery, thus mitigating complications and related costs. The acquisition of CE certification is crucial for commercial product sales in European, UK, and other international markets that recognize CE marks.

CEO Yuval Yaskil of Virtual-Ports Remarked

“Attaining the CE certification under the new MDR requirements not only allows Virtual-Ports to access a long-awaited multi-billion-dollar market, but it is also a testament to the quality and advancement of Virtual-Ports as a company. This milestone underscores our steadfast commitment to empowering surgeons and healthcare systems with cutting-edge solutions that promote safer and more cost-effective clinical outcomes.”

With the CE certification in hand, Virtual-Ports is poised to introduce its transformative technology to medical professionals and patients across Europe, further cementing its position as a leader in the surgical technology landscape.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.